LAB
Standard BioTools Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$0.93
+0.00 +0.23%
🌙 3월 13일 4:52 PM ET (한국 3/14 05:52)
$0.93
+0.00 -0.04%
| Index | RUT | P/E | - | EPS (ttm) | -0.2 | Insider Own | 4.15% | Shs Outstand | 0.38B | Perf Week | -5.82% |
| Market Cap | 0.36B | Forward P/E | - | EPS next Y | 23.68% | Insider Trans | 237.09% | Shs Float | 0.37B | Perf Month | -21.63% |
| Enterprise Value | 0.20B | PEG | - | EPS next Q | -0.04 | Inst Own | 77.18% | Short Float | 2.76% | Perf Quarter | -36.56% |
| Income | -0.07B | P/S | 3.39 | EPS this Y | 15.56% | Inst Trans | 1.21% | Short Ratio | 5.49 | Perf Half Y | -29.88% |
| Sales | 0.11B | P/B | 0.9 | EPS next 5Y | 15.3% | ROA | -10.42% | Short Interest | 10.16M | Perf YTD | -27.14% |
| Book/sh | 1.04 | P/C | 1.91 | EPS past 3/5Y | 56.76% 23.22% | ROE | -13.73% | 52W High | -45.78% ($1.72) | Perf Year | -15.22% |
| Cash/sh | 0.49 | P/FCF | - | Sales past 3/5Y | -4.49% -9.19% | ROIC | -16.66% | 52W Low | 1.37% ($0.92) | Perf 3Y | -50.92% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | 64.26% | Gross Margin | 47.3% | Volatility(W/M) | 5.68% 6.54% | Perf 5Y | -79.37% |
| Dividend TTM | - | EV/Sales | 1.91 | Sales Y/Y TTM | -39.29% | Oper. Margin | -93.84% | ATR (14) | 0.07 | Perf 10Y | -87.87% |
| Dividend Ex-Date | - | Quick Ratio | 4.01 | EPS Q/Q | 155.05% | Profit Margin | -70.72% | RSI (14) | 24.09 | Recom | 2.33 |
| Dividend Gr. 3/5Y | - | Current Ratio | 4.19 | Sales Q/Q | -49.07% | SMA20 | -12.89% ($1.07) | Beta | 1.41 | Target Price | $1.55 |
| Payout | - | Debt/Eq | 0.07 | Earnings | 2000000 | SMA50 | -26.78% ($1.27) | Rel Volume | 1.13 | Prev Close | $0.93 |
| Employees | 818 | LT Debt/Eq | 0.06 | EPS/Sales Surpr. | 174.21% 28.61% | SMA200 | -27.59% ($1.28) | Avg Volume(3M) | 1.85M | Price | $0.93 |
| IPO | 2011/2/10 | Option/Short | Yes/Yes | Trades | 7506 | Volume | 2,086,456 | Change | 0.23% |
뉴스 로딩 중...